A Study on the Safety and Immune Response of a Booster Dose of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Condition:   SARS-CoV-2 Interventions:   Biological: CV0701 Bivalent High dose;   Biological: CV0701 Bivalent Medium dose;   Biological: CV0701 Bivalent Low dose;   Biological: CV0601 Monovalent High dose;   Biological: Control vaccine Sponsors:   GlaxoSmithKline;   CureVac Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials